ZBH ZIMMER BIOMET HOLDINGS, INC. NYSE · United States

ZIMMER BIOMET HOLDINGS, INC. (ZBH) news

ZIMMER BIOMET HOLDINGS, INC. is a public biotech or pharmaceutical company listed on NYSE under the ticker ZBH, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest ZIMMER BIOMET HOLDINGS, INC. news

We have not published a story on ZIMMER BIOMET HOLDINGS, INC. yet. When there is news, it will appear here.

ZIMMER BIOMET HOLDINGS, INC. annual financials

Line	FY2025	FY2024
Revenue	$8.23 billion	$7.68 billion
Net income (loss)	$705.1 million	$903.8 million
Cash from operations	$1.70 billion	$1.50 billion
Cash and equivalents	$591.9 million	$525.5 million

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $410.0 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about ZIMMER BIOMET HOLDINGS, INC.

What is the ticker symbol of ZIMMER BIOMET HOLDINGS, INC.?

ZIMMER BIOMET HOLDINGS, INC. trades under the ticker ZBH on NYSE.

Where is ZIMMER BIOMET HOLDINGS, INC. listed?

ZIMMER BIOMET HOLDINGS, INC. is listed on NYSE.

Which country or territory is ZIMMER BIOMET HOLDINGS, INC. listed under?

Our directory records ZIMMER BIOMET HOLDINGS, INC. under United States.

Does aibio.space cover ZIMMER BIOMET HOLDINGS, INC.?

aibio.space lists ZIMMER BIOMET HOLDINGS, INC. among 2,820 public biotech companies and publishes its news here as stories appear.

What was ZIMMER BIOMET HOLDINGS, INC.'s revenue last year?

$8.23 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is ZIMMER BIOMET HOLDINGS, INC. profitable?

ZIMMER BIOMET HOLDINGS, INC. reported net income of $705.1 million for the fiscal year ended Dec 31, 2025, and generated $1.70 billion of cash from operations, per its annual report to the SEC.

How much cash does ZIMMER BIOMET HOLDINGS, INC. have?

$410.0 million in cash at Jun 30, 2026, per its 10-Q.

Investor discussion: ZIMMER BIOMET HOLDINGS, INC.

Members talk about ZIMMER BIOMET HOLDINGS, INC. (ZBH). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NYSE:ZBH on TradingView.

Listing details

Company: ZIMMER BIOMET HOLDINGS, INC.
Ticker: ZBH
Listing: NYSE
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction